Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Two-part, Phase 1, Open-label, Randomized, Parallel-arm, Fixed Sequence, Drug-drug Interaction Study to Investigate the Effect of Linerixibat on Plasma Concentrations of Obeticholic Acid and Conjugates in Healthy Adult Participants

Next Previous
X
Search
Trial Profile

A Two-part, Phase 1, Open-label, Randomized, Parallel-arm, Fixed Sequence, Drug-drug Interaction Study to Investigate the Effect of Linerixibat on Plasma Concentrations of Obeticholic Acid and Conjugates in Healthy Adult Participants

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 09 Nov 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Linerixibat (Primary) ; Obeticholic acid (Primary)
  • Indications Alcoholic hepatitis; Biliary atresia; Cholelithiasis; Crohn's disease; Non-alcoholic steatohepatitis; Obesity; Portal hypertension; Primary bile acid malabsorption; Primary biliary cirrhosis; Primary sclerosing cholangitis; Pruritus; Reperfusion injury; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline; GSK

    • Most Recent Events

    • 04 Nov 2022 Status changed from recruiting to completed.
    • 10 Jun 2022 Planned End Date changed from 4 Oct 2022 to 30 Nov 2022.
    • 10 Jun 2022 Planned primary completion date changed from 4 Oct 2022 to 30 Nov 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top